User assessment of Norditropin NordiFlex(®), a new prefilled growth hormone pen: a Phase IV multicenter prospective study

BACKGROUND/AIM: In growth disorders, ensuring long-term growth hormone therapy (GHT) remains a challenge that might compromise the clinical outcome. Consequently, strategies aiming at alleviating the burden of daily injection might improve the treatment benefit. The study reported here was performed...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tauber, Maithé, Jaquet, Delphine, Jesuran-Perelroizen, Monique, Petrus, Marc, Bertrand, Anne Marie, Coutant, Regis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2013
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3668964/
https://ncbi.nlm.nih.gov/pubmed/23737664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S43460
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak